Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 명기범 | * |
dc.contributor.author | 최혜영 | * |
dc.contributor.author | 최유원 | * |
dc.date.accessioned | 2016-08-28T12:08:47Z | - |
dc.date.available | 2016-08-28T12:08:47Z | - |
dc.date.issued | 2011 | * |
dc.identifier.issn | 1013-9087 | * |
dc.identifier.other | OAK-8356 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/222270 | - |
dc.description.abstract | Fexofenadine (Allegra. ®180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine- induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-basophil activation test. | * |
dc.language | English | * |
dc.title | Fexofenadine-induced urticaria | * |
dc.type | Article | * |
dc.relation.issue | SUPPL. 3 | * |
dc.relation.volume | 23 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.index | KCI | * |
dc.relation.startpage | S329 | * |
dc.relation.lastpage | S332 | * |
dc.relation.journaltitle | Annals of Dermatology | * |
dc.identifier.doi | 10.5021/ad.2011.23.S3.S329 | * |
dc.identifier.wosid | WOS:000298975400014 | * |
dc.identifier.scopusid | 2-s2.0-84863171055 | * |
dc.author.google | Lee S.W. | * |
dc.author.google | Byun J.Y. | * |
dc.author.google | Choi Y.W. | * |
dc.author.google | Myung K.B. | * |
dc.author.google | Choi H.Y. | * |
dc.contributor.scopusid | 명기범(7006220296) | * |
dc.contributor.scopusid | 최혜영(55724363200) | * |
dc.contributor.scopusid | 최유원(7404777738) | * |
dc.date.modifydate | 20231120161531 | * |